Support Page Content
Biosafety
The Institutional Biosafety Committee (IBC) is responsible for the review and approval of all research and academic activities involving recombinant and synthetic nucleic acid molecules; cells, organisms, and viruses containing such molecules; or other potentially hazardous biological agents to ensure that work is conducted in a manner that does not pose significant risk to the health and safety of laboratory workers, the public, or the environment.
Policy
Committee
The IBC was established and appointed in Fall 2025 and is developing the protocol submission and review process. The campus will be notified once submissions are required.
Meetings
- February 24, 2026, 12:00-1:00pm
Minutes
Guidance